Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Debt Ratio (2019 - 2025)

Vivos Therapeutics (VVOS) has disclosed Debt Ratio for 4 consecutive years, with 0.34 as the latest value for Q3 2025.

  • On a quarterly basis, Debt Ratio changed N/A to 0.34 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.34, a N/A change, with the full-year FY2021 number at 0.04, down 26.28% from a year prior.
  • Debt Ratio was 0.34 for Q3 2025 at Vivos Therapeutics, up from 0.3 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.34 in Q3 2025 to a low of 0.03 in Q2 2021.